Mr. Pfluger (for himself and Mr. Kustoff) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
To amend title XI of the Social Security Act to establish a research and development-intensive small biotech manufacturer exception from the Medicare drug price negotiation program.
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. Small Biotech Innovation Act. H.R. 3731. 119th
Cong., 1st
sess., Introduced in House June 4, 2025. https://www.govinfo.gov/app/details/BILLS-119hr3731ih.
APA
Congress, House of Representatives (2025, June 4). Small Biotech Innovation Act (H.R. 3731 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119hr3731ih.
MLA
United States, Congress, House of Representatives. Small Biotech Innovation Act. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119hr3731ih. 119th Congress, H.R. 3731, Introduced in House 4 Jun. 2025.
Bluebook
H.R.3731 - 119th Congress (2025-2026): Small Biotech Innovation Act, H.R.3731, 119th Cong. (2025), https://www.govinfo.gov/app/details/BILLS-119hr3731ih.
